Antisperm antibodies (ASA) occur in men and women and may significantly impair fertility. The identification of functionally rele vant antigens of ASA is important for establishing causal treatment options on the one hand and may, on the other hand, enhance the de velopment of tools for immunocon traception. One candidate protein is addressed in an article of Wang et al. [1] The testis is an immunologi cally privileged site where germ cell antigens are protected from au toimmune attack [2, 3] . However, due to disruption of the blood testis barrier occurring from tes ticular injury, or as a consequence of trauma to the epididymis or vas deferens many testicular isoen zymes and other proteins get auto antigenic during immunological challenges resulting in the forma tion of ASA in the blood serum, seminal plasma or located on the sperm membrane. ASA have also been reported to be associated with inflammation, cryptor chidism, vari cocele and surgical intervention in the genital organs [4] . ASA may interfere with different sperm func tions essential for the fertilization process. However, the problem is to detect whether or not ASA of an indivi dual man are of func tional relevance, i.e. whether the ASA binding to a sperm surface antigen also influences sperm func tion and which one. In previous studies several antibodybinding proteins have been characterized in isolated sperm surface mem branes and seve ral proteins have been described whose ASA could be associated with agglutinations [5] , motility [6] , cervix mucus pen etration [7] , acrosome reaction [8] , zona binding [9] and penetration and oolemma binding [10] . NASP has been found to be important for the pronucleus formation to which most vasectomized men develop autoantibodies [11] . In the present study several important results re garding NASP have been obtained:
1. Spermegg binding and IVF of mouse oocytes with capacitated mouse spermatozoa were inhibited in the presence of antisera against NASP.
2. AntiNASP did not change sperm motility.
3. Sera from infertile men containing antisperm antibodies re acted with antiNASP.
4. After immunization of fer tile female mice with NASP the pregnancy rate was significantly reduced and the reduction in litter size correlated with the antibody titer.
Depending on the immunogen used (recombinant mouse NASP) or a synthetic peptide (human NASP), npg the immunized mice regained ferti lity at rates comparable to those of the control mice after the antibody titer had declined or the animals remained infertile (immunized with mouse NASP). With regard to the mechanism by which fertility is disturbed-inhibition of spermegg binding and IVF-it is speculated that the antibody effect must be as sociated with the cell surface and not with the cytoplasm or nucleus. This is a little bit in contrast to the fact that NASP has been shown to be located mainly over the nucleus and only partly in the acrosome [12] : here the authors discuss that some part of the NASP may be exposed for a short time when it is carried into the ovum with the sperm nucleus at fertilization. This question can be answered after per forming intra cytoplasmic sperm injection (ICSI), which will be the next step in a further study an nounced by the authors in order to investigate the direct effects of the antiNASP antibodies on embryo development and implantation. As ICSI is suggested as the ap propriate treatment to overcome antisperm antibodies`action on the one hand, and-according to my own experience-fertilization and pregnancy rates are lower in couples with male immunologi cal inferti lity compared to couples without antisperm antibodies in the male, even when ICSI is ap plied, it will be very interesting to see what these future studies will reveal. They will probably show that it is not an antibody against a single sperm antigen that causes a significant reduction of fertility, but is more likely multiple ASAs that contribute to an individual ferti lity problem. Future results will increase our understanding of the specific mechanisms that elicit the autoimmune response and of the active profile of ASA that leads to an antibodymediated infertility. Thus, specific therapies based on the use of monoclonal antibodies as well as new approaches to male immune contraception may be developed.
